Abstract
The risk of cancer and dementia increases with age, raising complex questions about whether it is appropriate to continue cancer treatment in older patients. There is emerging research suggesting the association between cancer and dementia. However, the mechanistic underpinnings are still under investigation. Progress has already been made toward understanding the cognitive effects associated with cancer therapy. Such associations raise awareness about the need to establish better prevention methods and early screening in clinical practice. Additionally, recent studies have suggested possible therapeutic strategies for better preserving cognitive function and reducing the risk for dementia before patients start cancer treatment. We review the current literature and summarize the incidence and mechanisms of cognitive impairment in patients with lung cancer, breast cancer, head and neck cancer, gastric cancer, prostate cancer, colorectal cancer, and brain tumor/brain metastasis following different kinds of therapies. Possible risk factors are suggested to identify the early onset of cognitive changes in cancer patients and provide more insight into the pathophysiological process of dementia.
Funder
National Science and Technology Council
Reference92 articles.
1. The hallmarks of cancer;Hanahan;Cell,2000
2. Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours;Makale;Nat. Rev. Neurol.,2017
3. (2022). Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: An analysis for the Global Burden of Disease Study 2019. Lancet Public Health, 7, e105–e125.
4. Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers;Reitz;Biochem. Pharmacol.,2014
5. Non-alcoholic fatty liver disease and the risk of dementia: A meta-analysis of cohort studies;Lu;Clin. Mol. Hepatol.,2022
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献